Skip to main content

Information on the use of Mounjaro (Tirzepatide) for weight management

Tirzepatide (Mounjaro) is a weight loss drug that was approved by the National Institute for Health and Care and Excellence (NICE) in the UK on 23 December 2024.

Please visit www.nhsglos.nhs.uk/your-health-services/healthy-communities/weight-loss-medication/ for more information.

Doctors

Dr Tristan Lench, male

Partner
MB ChB MRCGP MRCSEd MFAEM DRCOG DCH DTM&H

Dr Dur-E-Shahwar Shahid, female

Partner
MBBS DRCOG MRCGP DIP (Diabetes) DFSRH

Dr Shahid qualified as a doctor in 1996 and since that time has gained a wide range of experience across palliative medicine, emergency medicine, trauma and orthopaedics, obstetrics and gynaecology as well as general medicine.

Dr Shahid is particularly interested in care of the elderly, diabetes and family planning.

Related information

Named GP

Page published: 5 May 2023
Last updated: 30 July 2024